Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity-Reference-Cited by-同舟云学术

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Published:2010-04-19 Issue:1 Volume:334 Page:171-181
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Ishibashi Tadashi,Horisawa Tomoko,Tokuda Kumiko,Ishiyama Takeo,Ogasa Masaaki,Tagashira Rie,Matsumoto Kenji,Nishikawa Hiroyuki,Ueda Yoko,Toma Satoko,Oki Hitomi,Tanno Norihiko,Saji Ikutaro,Ito Akira,Ohno Yukihiro,Nakamura Mitsutaka

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference49 articles.

1. Positive and Negative Symptoms in Schizophrenia

2. Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

3. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment

4. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia;Barnes;Int Clin Psychopharmacol,1998

5. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo;Bersani;Clin Neuropharmacol,1990

Cited by 371 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prominently selective fluorescence approach with distinctive biopharmaceutical utility for analysis of lurasidone in human plasma and urine: Application to in vitro dissolution and content uniformity testing;Luminescence;2024-09

2. Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis;Drugs in Context;2024-08-05

3. Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets;Substance Abuse and Rehabilitation;2024-08

4. Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial;Psychiatry Investigation;2024-07-25

5. The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults;International Clinical Psychopharmacology;2024-07-22